180 related articles for article (PubMed ID: 21163758)
1. [Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
Magy Onkol; 2010 Dec; 54(4):283-8. PubMed ID: 21163758
[TBL] [Abstract][Full Text] [Related]
2. [Health insurance reimbursement of dental care in Hungary].
Marada G; Nagy A; Benke B; Boncz I
Fogorv Sz; 2012 Mar; 105(1):3-8. PubMed ID: 22530363
[TBL] [Abstract][Full Text] [Related]
3. [Health economics of oncology care: financial effect of performance volume limit (PVL)].
Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
Magy Onkol; 2010 Mar; 54(1):35-9. PubMed ID: 20350866
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary].
Kívés Z; Endrei D; Elmer D; Csákvári T; Kajos LF; Boncz I; Mangel L; Mihály-Vajda R
Orv Hetil; 2021 Mar; 162(162 Suppl 1):14-21. PubMed ID: 33774604
[TBL] [Abstract][Full Text] [Related]
5. [Annual epidemiological and health insurance disease burden of pertrochanteric fractures in Hungary].
Gazsó T; Elmer D; Endrei D; Sebestyén A; Kajos LF; Wiegand N; Boncz I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):46-53. PubMed ID: 33774608
[TBL] [Abstract][Full Text] [Related]
6. [Health economics analysis of colorectal screening].
Boncz I; Sebestyén A; Dózsa C; Pál M; Sándor J; Palásti J; Betlehem J; Ember I
Magy Onkol; 2004; 48(2):111-5. PubMed ID: 15351803
[TBL] [Abstract][Full Text] [Related]
7. Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary.
Hornyák L; Nagy Z; Ilku L; Tálos Z; Endrei D; Ágoston I; Csákvári T; Danku N; Répásy B; Boncz I
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):725-731. PubMed ID: 30763134
[No Abstract] [Full Text] [Related]
8. [Priorisation in health-care; drug-reimbursement priorities in Hungary in 2004].
Kárpati K; Brandtmüller A; Májer I; Gulácsi L
Acta Pharm Hung; 2006; 76(4):191-9. PubMed ID: 17575799
[TBL] [Abstract][Full Text] [Related]
9. [Nationwide epidemiological and health insurance disease burden of rheumatoid arthritis in Hungary].
Elmer D; Endrei D; Sebestyén A; Csákvári T; Németh N; Horváth L; Pónusz R; Kumánovics G; Boncz I; Ágoston I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):30-37. PubMed ID: 33774606
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of generic price competition on the Hungarian statin market.
Répásy B; Gazsó T; Elmer D; Pónusz-Kovács D; Kajos FL; Csákvári T; Kovács B; Boncz I
BMC Health Serv Res; 2023 May; 23(1):447. PubMed ID: 37147682
[TBL] [Abstract][Full Text] [Related]
11. [Health insurance pharmaceutical expenditures in Hungary].
Eisingerné Balassa B; Csákvári T; Ágoston I
Orv Hetil; 2019 Feb; 160(Suppl 1):49-54. PubMed ID: 30724598
[TBL] [Abstract][Full Text] [Related]
12. [The effect of generic price competition on drug consumption and health insurance pharmaceutical expenditures in Hungary].
Répásy B; Endrei D; Zemplényi A; Agoston I; Hornyák L; Nagy Z; Csákvári T; Vajda R; Boncz Imre
Acta Pharm Hung; 2015; 85(3):83-8. PubMed ID: 26642646
[TBL] [Abstract][Full Text] [Related]
13. [Physiotherapy from the view of health insurance financing].
Géher P
Orv Hetil; 2013 Dec; 154(48):1917-23. PubMed ID: 24273291
[TBL] [Abstract][Full Text] [Related]
14. [FINANCING OF MEDICINES FOR TREATMENT OF RARE DISEASES OF THE NERVOUS SYSTEM. ORPHAN DRUGS IN RARE NEUROLOGICAL DISEASES].
Szegedi Márta ; Kosztolányi G; Boncz I; Molnár MJ
Ideggyogy Sz; 2016 Jan; 69(1-2):37-45. PubMed ID: 26987239
[TBL] [Abstract][Full Text] [Related]
15. [Experiences with the Introduction of Diagnosis Related Groups (DRG) in the Hungarian Ophthalmology].
Lampé Z; Boncz I; Sebestyén A; Berta A
Klin Monbl Augenheilkd; 2007 Jul; 224(7):575-9. PubMed ID: 17657691
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of health insurance costs in cases of patients under 60 years old with medial femoral neck fracture treated primarily with screw fixation or hip replacement].
Sebestyén A; Boncz I; Nyárády J
Orv Hetil; 2006 Jun; 147(24):1129-35. PubMed ID: 16865858
[TBL] [Abstract][Full Text] [Related]
17. [Health economics analysis of breast cancer screening].
Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
[TBL] [Abstract][Full Text] [Related]
18. [Annual epidemiological and health insurance burden of cervical cancer in Hungary].
Mihály-Vajda R; Boncz I; Elmer D; Csákvári T; Németh N; Kajos LF; Pónusz-Kovács D; Bódis J; Kívés Z
Orv Hetil; 2021 Mar; 162(162 Suppl 1):22-29. PubMed ID: 33774605
[TBL] [Abstract][Full Text] [Related]
19. [The nationwide epidemiological and health insurance disease burden of knee and lower leg injuries in Hungary].
Varga V; Elmer D; Boncz I; Sipos D; Kajos LF; Sebestyén A; Molics B
Orv Hetil; 2021 Mar; 162(162 Suppl 1):54-60. PubMed ID: 33774609
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological disease burden and annual health insurance treatment cost of acute myocardial infarction in Hungary].
Németh N; Endrei D; Elmer D; Csákvári T; Horváth L; Kajos LF; Cziráki A; Boncz I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):6-13. PubMed ID: 33774610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
